Kreos Capital

Venture Capital United Kingdom Est. 1998
Last updated 2026-06-18
Portfolio
22
in our dataset
Rounds participated
25
Rounds led
8
Rounds' value
$475.4M
total disclosed, rounds participated
Stages
F Round, G Round, E Round, D Round

About

Kreos Capital has for more than 20 years provided financing to high-growth companies with revenues of up to 150 million. To date, it has committed over 2.6 billion across six funds to more than 570 portfolio company transactions in a variety of industry sectors, located in 16 countries.

Focusing on the value creation of its portfolio companies, Kreos takes both a credit and an equity view of each financing situation, offering quick feedback on any deal proposal and investing without the need for board seats, time-consuming audits, share revaluation, substantial equity dilution, deposits, or personal guarantees.

The Kreos team has the necessary experience to understand what companies across all stages require and is able to provide debt-funding facilities that meet the real-world demands of growing businesses, equity sponsors, and investors.

Kreos was acquired by BlackRock Inc.

Portfolio · 22

BiolineRx
Oncology Therapeutic Pharmaceutical Candidates
Led ★ 2 rounds $40.0M committed Latest: 2024-04
Fairtility
AI-powered IVF Solutions
Led ★ 1 round Latest: 2024-02
AKEYLESS
Unified Secrets and Non-Human Identity (NHI) Platform
Led ★ 1 round Latest: 2024-02
Percepto
Autonomous Inspection and Monitoring Solution for Monitoring Critical Infrastructure
Led ★ 1 round $17.0M committed Latest: 2023-05
Ibex Medical Analytics
AI-powered Cancer Diagnostics for Pathologists
Led ★ 1 round $10.0M committed Latest: 2022-11
Variantyx
Advanced Genomic Diagnostic Solutions
1 round $20.0M committed Latest: 2022-10
PolyPid
Polymer Lipid Encapsulation Technology
1 round $12.5M committed Latest: 2022-04
Cakewalk
End-to-end Business Management Platform for Creators
Led ★ 1 round $3.3M committed Latest: 2022-02
Motus GI
Colon Cleansing for Colonoscopy
Led ★ 1 round $12.0M committed Latest: 2021-07
Quali
Infrastructure Orchestration and Automation Platform
2 rounds $76.5M committed Latest: 2021-01
Syte
Visual AI Platform for Retail
1 round $30.0M committed Latest: 2020-10
Gett
Ground Travel Platform for Businesses
2 rounds $132.0M committed Latest: 2019-05
BioCatch
Al-driven Behavioral Biometrics for Cybersecurity
1 round $31.0M committed Latest: 2018-03
Teridion Technologies
Overlay Network Solution for Increased Internet Performance
1 round $6.0M committed Latest: 2017-01
Ionir
Enterprise Cloud Data Storage and App Management
Led ★ 1 round $6.0M committed Latest: 2016-09
Zooz
Smart Open Payment Processing Platform
1 round $24.0M committed Latest: 2016-05
Lifeward
Battery-powered Walking System
1 round $20.0M committed Latest: 2016-01
Bluevine
Small Business Banking Solution
1 round $4.0M committed Latest: 2014-03
Wilocity
Wireless Chipsets for the Notebook and Peripheral Markets
1 round Latest: 2012-06
Trig Medical
Ultrasound Tracking and Monitoring Solutions for Childbirth
1 round $4.1M committed Latest: 2009-08
Celtro Communication
Mobile Backhaul Optimization
1 round $20.0M committed Latest: 2008-06
Iamba
Gigabit Passive Optical Networking
1 round $7.0M committed Latest: 2008-05

Investment activity

6 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences8
Industrial Technologies4
Business Software3
Media & Entertainment Technologies2
Cyber Security2
Fintech & Insurtech2
Automotive & Mobility Technologies1
Undisclosed1

Q&A

What was Kreos Capital's most recent exit?
Kreos Capital's most recent exit was BioCatch, which was acquired by Permira in May 2024 for $750M.
Which sectors does Kreos Capital primarily invest in?
Kreos Capital shows a strong concentration in Health Tech & Life Sciences with 8 portfolio companies, followed by Industrial Technologies with 4, and Business Software with 3.
Can you name some of Kreos Capital's notable portfolio companies?
Kreos Capital's portfolio includes companies like AKEYLESS, which is a unified secrets and non-human identity platform, and BioCatch, an AI-driven behavioral biometrics company for cybersecurity.
What is Kreos Capital's investment stage focus?
Kreos Capital primarily invests in later stages, with listed investment stages including F Round, G Round, E Round, and D Round. Their funding rounds data also shows a significant number of C Round and Debt Financing investments.
How many exits has Kreos Capital had in the last two years?
Kreos Capital has had one exit in the last two years, with BioCatch being acquired in May 2024.
What is the total capital raised by some of Kreos Capital's portfolio companies?
Notable portfolio companies include Bluevine, which has raised $286M, and Gett, which has raised $708M.
What is the geographic focus of Kreos Capital?
Kreos Capital is headquartered in the United Kingdom and has a global investment scope, with portfolio companies located in 16 countries.
Who are some of the key personnel at Kreos Capital?
Key personnel at Kreos Capital include Uri Galai, a Managing Director, and Parag Gandesha, a Managing Director & COO.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)